Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Comment by cleareyeon Jul 25, 2021 3:48pm
149 Views
Post# 33602299

RE:Get intimate with the details for perspective.

RE:Get intimate with the details for perspective. Good Post Factfinder1994.

It's a difficult month for SQD. The waiting game is never helpful or happy.

However, as you said, the larger decision is still yet to be made. The more lucrative issue is still before the FDA.

I expect that the stock price will drop on Monday, because it is hard for those who aren't intimate with the details to know what to do. It doesn't help that the CEO left the company - not at all. However to have Clive Beddoes put his reputation on the line is very helpful.

Where we used to have 100 horses pulling us forward, we now have 95.  I'm sitting in my seat on this stagecoach. However, I will hold the door for those who wish to leave, and then shut it again and carry on my journey.

Have a good week everyone,

cleareye.
<< Previous
Bullboard Posts
Next >>